Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 23Prostatic Neoplasms 12Lung Neoplasms 12Colorectal Neoplasms 12Neoplasms 9Pancreatic Neoplasms 6Lymphoma 6Hematologic Neoplasms 6Uterine Cervical Neoplasms 5Ovarian Neoplasms 5Triple Negative Breast Neoplasms 4Neoplasm Metastasis 4Melanoma 4Hematopoietic and Lymphatic System Neoplasm 4Urinary Bladder Neoplasms 3Sarcoma 3Papillomavirus Infections 3Obesity-Related Malignant Neoplasm 3Obesity 3Motor Activity 3Endometrial Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Carcinoma In Situ 3Anatomic Stage I Breast Cancer AJCC v8 3Vulvar Neoplasms 2Testicular Neoplasms 2Smoking Cessation 2Skin Carcinoma 2Rectal Neoplasms 2

Interventions

sotrovimab 1ciclesonide 1cabozantinib 1anifrolumab 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Platinum Compounds 1Nivolumab 1Niclosamide 1Methods 1Ipilimumab 1Interviews as Topic 1Immune Checkpoint Inhibitors 1High-Intensity Interval Training 1Exercise 1Educational Status 1Early Intervention, Educational 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lupus Erythematosus, Systemic × Methods × 1 year × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡